Home › Bronchiolitis Obliterans Syndrome › Texas
Bronchiolitis Obliterans Syndrome clinical trials in Texas
12 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in Texas.
Cities in Texas
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
- Texas Children's Hospital- Site Number : 8400008, Houston
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 22, 2026 · NCT07116031An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
- Baylor University Jamail Specialty Care Center- Alkek Eye Center- Ophthalmology, Houston
RecruitingPhase 3
Ages 10 to 65 · All sexes · Updated Sep 21, 2026 · NCT07395232A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- St David'S South Austin Medical Center, Austin
- Texas Transplant Institute, San Antonio
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT06585774Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
- The University of Texas M. D. Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07127926Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05919511UTSW NORC Pilot Spinal Cord Injury Dietary Program
- University of Texas Southwestern Medical Center, Dallas
Recruiting
Ages 18 to 65 · All sexes · Updated Jul 15, 2026 · NCT06924177Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
- Memorial Hermann Hospital / UTHealth McGovern Medical School at Houston, Houston
- The University of Texas Health Science at San Antonio, San Antonio
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Jul 15, 2026 · NCT05951777A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Baylor College of Medicine, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06615050Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
- Baylor College of Medicine, Houston
Recruiting
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT06464926Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT06434363A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- St. David's South Austin Medical Center, Austin
- UT Southwestern Medical Center, Dallas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561Freedom-1 Study for Chronic Knee Pain
- Austin Orthopedic Institute, Austin
- Performance pain and sports medicine, Houston
- Advanced Spine and Pain Center, San Antonio
Recruiting
Ages 18 and older · All sexes · Updated Feb 13, 2025 · NCT03877653From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.